PYXS is trading at $3.30 (15.4%) in pre-market following an announcement of an up to $114 million private placement financing. - The financing, led by BVF Partners, aims to extend the cash runway and fund its lead candidate, MICVO, through key clinical milestones. - This comes as the stock extends a multi-day rally, influenced by its June 29 inclusion in the Russell Microcap Growth Index. - Shares previously gained 24.22% on June 26 and 3.25% on June 29.